Neuronetics Inc (NASDAQ:STIM) has a beta value of 1.77 and has seen 1.14 million shares traded in the last trading session. The company, currently valued at $247.27M, closed the last trade at $3.74 per share which meant it lost -$0.12 on the day or -3.11% during that session. The STIM stock price is -58.29% off its 52-week high price of $5.92 and 86.1% above the 52-week low of $0.52. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.79 million shares traded. The 3-month trading volume is 796.78K shares.
The consensus among analysts is that Neuronetics Inc (STIM) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.08.
Neuronetics Inc (NASDAQ:STIM) trade information
Sporting -3.11% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the STIM stock price touched $3.74 or saw a rise of 6.5%. Year-to-date, Neuronetics Inc shares have moved 100.00%, while the 5-day performance has seen it change 9.36%. Over the past 30 days, the shares of Neuronetics Inc (NASDAQ:STIM) have changed -1.84%. Short interest in the company has seen 3.11 million shares shorted with days to cover at 5.27.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 53.25% from current levels. The projected low price target is $8.0 while the price target rests at a high of $8.0. In that case, then, we find that the current price level is -113.9% off the targeted high while a plunge would see the stock gain -113.9% from current levels.
Neuronetics Inc (STIM) estimates and forecasts
The company’s shares have gained 118.71% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 102.24%.
3 analysts offering their estimates for the company have set an average revenue estimate of 36.8M for the current quarter. 3 have an estimated revenue figure of 38.31M for the next ending quarter. Year-ago sales stood 16.45M and 18.53M respectively for this quarter and the next, and analysts expect sales will grow by 123.68% for the current quarter and 102.24% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 2.71% over the past 5 years.
STIM Dividends
Neuronetics Inc is expected to release its next earnings report on 2025-May-06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
Insiders own 9.17% of the company shares, while shares held by institutions stand at 62.80% with a share float percentage of 69.15%. Investors are also buoyed by the number of investors in a company, with Neuronetics Inc having a total of 110.0 institutions that hold shares in the company. The top two institutional holders are ARCHON CAPITAL MANAGEMENT LLC with over 2.47 million shares worth more than $4.45 million. As of 2024-06-30, ARCHON CAPITAL MANAGEMENT LLC held 8.23% of shares outstanding.
The other major institutional holder is CANNELL CAPITAL LLC, with the holding of over 2.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $4.29 million and represent 7.9239% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 2.73% shares in the company for having 1.81 shares of worth $6.76 million while later fund manager owns 429.32 shares of worth $1.61 million as of Mar 31, 2025 , which makes it owner of about 0.65% of company’s outstanding stock.
